Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 2
2005 1
2006 5
2007 6
2008 3
2009 3
2010 4
2011 8
2012 13
2013 14
2014 25
2015 9
2016 17
2017 13
2018 15
2019 13
2020 16
2021 14
2022 11
2023 13
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis.
Chavez JC, Grajales A, Sandoval-Sus J, Turba E, Nodzon L, Uriepero-Palma A, Ammad-Ud-Din M, Sahakian E, Komrokji R, Sokol L, Locke FL, Shah B, Lancet J, Sotomayor EM, Kharfan-Dabaja MA, Bello C, Pinilla-Ibarz J. Chavez JC, et al. Among authors: sokol l. Clin Lymphoma Myeloma Leuk. 2024 Feb 13:S2152-2650(24)00060-0. doi: 10.1016/j.clml.2024.02.001. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38508880 Free article.
B-cell maturation antigen expression and clinical features of plasmablastic lymphoma.
Dong N, Zhang H, Song J, Mammadova J, Shah B, Saeed H, Gaballa S, Grajales-Cruz A, Isenalumhe L, Bello C, Sokol L, Pinilla J, Chavez J. Dong N, et al. Among authors: sokol l. EJHaem. 2024 Jan 18;5(1):285-289. doi: 10.1002/jha2.807. eCollection 2024 Feb. EJHaem. 2024. PMID: 38406544 Free PMC article. No abstract available.
Sézary syndrome originates from heavily mutated hematopoietic progenitors.
Harro CM, Sprenger KB, Chaurio RA, Powers JJ, Innamarato P, Anadon CM, Zhang Y, Biswas S, Mandal G, Mine JA, Cortina C, Nagy MZ, Martin AL, Handley KF, Borjas GJ, Chen PL, Pinilla-Ibarz J, Sokol L, Yu X, Conejo-Garcia JR. Harro CM, et al. Among authors: sokol l. Blood Adv. 2023 Sep 26;7(18):5586-5602. doi: 10.1182/bloodadvances.2022008562. Blood Adv. 2023. PMID: 37531660 Free PMC article.
Insights into the Impact of Hesitancy on Cancer Care and COVID-19.
Visweshwar N, Rico JF, Ayala I, Jaglal M, Laber DA, Ammad-Ud-Din M, Sokol L, Sotomayor E, Manoharan A. Visweshwar N, et al. Among authors: sokol l. Cancers (Basel). 2023 Jun 8;15(12):3115. doi: 10.3390/cancers15123115. Cancers (Basel). 2023. PMID: 37370725 Free PMC article. Review.
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.
Ruan J, Moskowitz A, Mehta-Shah N, Sokol L, Chen Z, Kotlov N, Nos G, Sorokina M, Maksimov V, Sboner A, Sigouros M, van Besien K, Horwitz S, Rutherford SC, Mulvey E, Revuelta MV, Xiang J, Alonso A, Melnick A, Elemento O, Inghirami G, Leonard JP, Cerchietti L, Martin P. Ruan J, et al. Among authors: sokol l. Blood. 2023 May 4;141(18):2194-2205. doi: 10.1182/blood.2022018254. Blood. 2023. PMID: 36796016 Clinical Trial.
185 results